Trihexyphenidyl Potentiation ofl-DOPA: Reduced Effectiveness Three Years Later in MPTP-Induced Chronic Hemiparkinsonian Monkeys

By Domino E.F.   Ni L.  

Experimental Neurology, Vol. 152, Iss. 2, 1998-08 ,pp. : 238-242

Elsevier

Access to resources Recommend Favorite

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates

By Kuoppamäki M.   Al-Barghouthy G.   Jackson M. J.   Smith L. A.   Quinn N.   Jenner P.  

Journal of Neural Transmission, Vol. 114, Iss. 9, 2007-09 ,pp. : 1147-1153

Springer Publishing Company

Access to resources Recommend Favorite

Dopa-Induced Blood Flow Responses in Nonhuman Primates

By Hershey T.   Black K.J.   Carl J.L.   Perlmutter J.S.  

Experimental Neurology, Vol. 166, Iss. 2, 2000-12 ,pp. : 342-349

Elsevier

Access to resources Recommend Favorite

MPTP-Induced Pallidal Lesions in Rhesus Monkeys

By Zhang Z.   Zhang M.   Ai Y.   Avison C.   Gash D.M.  

Experimental Neurology, Vol. 155, Iss. 1, 1999-01 ,pp. : 140-149

Elsevier

Access to resources Recommend Favorite

Dopamine Agonist 3-PPP Fails to Protect Against MPTP-Induced Toxicity

By Muralikrishnan Dhanasekaran   Ebadi Manuchair   Brown-Borg Holly M.  

Neurochemical Research, Vol. 29, Iss. 2, 2004-02 ,pp. : 379-384

Springer Publishing Company

Access to resources Recommend Favorite